⚡A study forecasts that global cervical cancer cases and deaths will rise by 2050.

What it means

A new Nature Medicine modeling study, drawing on Global Burden of Disease estimates, projects that cervical cancer incidence and deaths will keep rising to 2050 under current trends: roughly +20% for new cases and +39% for deaths, with annual deaths reaching about 522,000 by mid-century and the steepest increases in sub-Saharan Africa. The figures are model forecasts, not observed counts, and they illustrate how far the world remains from the WHO goal of eliminating cervical cancer without broader HPV vaccination, screening, and treatment access.

Accuracy & sourcesSourced

This is the primary peer-reviewed source itself (Nature Medicine, DOI 10.1038/s41591-026-04729-4), so the headline figures are the study's own projections; press coverage from Xinhua and Medical Xpress is consistent with the abstract. As a forecast rather than an observed outcome, its certainty is limited by the model's assumptions about current trends continuing.

How new

Genuinely new: the paper and its coverage date from early November 2026, with no recirculation of older material.

Past coverage

We covered a broader global cancer projection in September 2026, when a study forecast cancer cases could surge 67% by 2050; this cervical-cancer-specific forecast is a narrower follow-up on one tumor type.

Go deeper